SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASE
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | IBRO Neuroscience Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667242123022248 |
_version_ | 1797636080582787072 |
---|---|
author | Stefan Lichtenthaler |
author_facet | Stefan Lichtenthaler |
author_sort | Stefan Lichtenthaler |
collection | DOAJ |
first_indexed | 2024-03-11T12:29:03Z |
format | Article |
id | doaj.art-d785d976069241a5a31bf15925dddd54 |
institution | Directory Open Access Journal |
issn | 2667-2421 |
language | English |
last_indexed | 2024-03-11T12:29:03Z |
publishDate | 2023-10-01 |
publisher | Elsevier |
record_format | Article |
series | IBRO Neuroscience Reports |
spelling | doaj.art-d785d976069241a5a31bf15925dddd542023-11-06T04:28:59ZengElsevierIBRO Neuroscience Reports2667-24212023-10-0115S53SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASEStefan Lichtenthaler0German Center for Neurodegenerative Diseases (DZNE), Neuroproteomics, Munich, Germanyhttp://www.sciencedirect.com/science/article/pii/S2667242123022248 |
spellingShingle | Stefan Lichtenthaler SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASE IBRO Neuroscience Reports |
title | SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASE |
title_full | SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASE |
title_fullStr | SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASE |
title_full_unstemmed | SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASE |
title_short | SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASE |
title_sort | shedding of trem2 and app as drug targets in alzheimer s disease |
url | http://www.sciencedirect.com/science/article/pii/S2667242123022248 |
work_keys_str_mv | AT stefanlichtenthaler sheddingoftrem2andappasdrugtargetsinalzheimersdisease |